Fig. 1: Forest plot analyses to evaluate the association between BMI ≥ 25 (vs BMI 18.5–24.9) and 1-year treatment-related amenorrhea are shown.
From: Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer
A consistent association between BMI ≥ 25 and a lower odds of 1-year TRA was present among each age group and by receipt or non-receipt of chemotherapy and tamoxifen.
